Intravesical drug delivery systems often fail to satisfy the requirement of multifunctionality in one entity, including mucoadhesion, tumor-selective binding and deep tumor-penetration. In this work, we engineered the surface of M1-like macrophages with both tumor-targeted and mucoadhesive ligands (R11) to develop a multifunctional cell vehicle (M1 R11 ) for intravesical delivery of ICG. Remarkably, M1 R11 corrected the lysosomal trafficking of ICG, directed it to enter the transcellular pathway and thereby enhance its intra-tumoral penetration. When intravesically applied, the M1 R11 -delivered ICG displayed much improved photodynamic efficacy, ultimately eradicating orthotopic bladder tumors in most cases and achieving complete pathological response.